Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies
Redx Pharma Ltd
Redx Pharma Ltd
National Institutes of Health Clinical Center (CC)
Sumitomo Pharma America, Inc.
Xencor, Inc.
Augusta University
M.D. Anderson Cancer Center
Duke University
Stanford University
Third Military Medical University
Samsung Medical Center
St. Luke's-Roosevelt Hospital Center
Indiana University
Federico II University